INTERPACE BIOSCIENCES, INC. (IDXG) Total liabilities 2016–2025
INTERPACE BIOSCIENCES, INC. (IDXG) total liabilities at each fiscal year-end, per SEC filings.
$11.5MFY2025 · since FY2016: $35.2M → $11.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $11.5M | -32.5% |
| FY2024 | $17.0M | -23.1% |
| FY2023 | $22.1M | -32.0% |
| FY2022 | $32.5M | -5.2% |
| FY2021 | $34.3M | +21.5% |
| FY2020 | $28.2M | -5.4% |
| FY2019 | $29.8M | +90.3% |
| FY2018 | $15.7M | +14.2% |
| FY2017 | $13.7M | -61.0% |
| FY2016 | $35.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice